StocksFin Logo
Pacira BioSciences, Inc...
Pacira BioSciences, Inc. country of incorporation
|
https://www.pacira.com
|
Mr. David Stack
|
697 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
STAAR Surgical Company
STAAR Surgical Company country of incorporation
|
https://www.staar.com
|
Ms. Caren Mason
|
692 employees
NASDAQ | Healthcare | Medical Instruments & Supplies
Q322 reported Nov 3, 2022 Reporting Period
$167.47M 31.1% vs. Q321 Revenues Q322
69.74% -4.3% vs. Q321 Gross Profit Margin
-0.41% ! -103% vs. Q321 Net Profit Margin
37.47M -37.8% vs. Q321 Free Cash Flow Q322
$-0.02 ! -105% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 2, 2022 Reporting Period
$76.05M 30.3% vs. Q321 Revenues Q322
79.51% 2.4% vs. Q321 Gross Profit Margin
13.49% 30.8% vs. Q321 Net Profit Margin
17.84M -20.1% vs. Q321 Free Cash Flow Q322
$0.21 61.5% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
3.21
5.94
Current Ratio
4.06
6.55
Cash Ratio
0.83
2.85
Price to Book
3.17
10.6
Price to Sales
14.56
44.63
Price to Earnings
-879.42
82.67